Thu, 8 March 2012
In this edition of Genome Barks, Dr. Nick Duesbery, Co-Director of the Van Andel Research Institute’s Center for Comparative Biology and Genetics, discusses the Canine Hereditary Cancer Consortium (CHCC), a national alliance of researchers with a common hope of improving the health and welfare of humans afflicted with rare tumors, and canines affected with the same respective cancer. Dr. Duesbery credits a CHF research grant for helping set the groundwork for what eventually grew into the CHCC. CHCC researchers are unraveling the genetic causes of several cancers, including but not limited to: hemangiosarcoma, osteosarcoma, melanoma, malignant histiocytic sarcoma, and lymphoma.
This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.